Well established company in India into design, manufacture, and installation of marketing signs is looking for a joint venture partner to expand operations in this fast-growing market. They currently have a strong client base in real estate across all major Indian cities. We can help with permits, leasing of units, legal, accounting etc.,
Opportunities
Joint Venture
Investment
CloudMD is a health-tech company poised to take advantage of the $10 trillion untapped virtual care market.
We have developed an innovative healthcare platform in collaboration with IBM that places the power back in the hands of the patients. Through CloudMD patients can be connected directly to a physician within minutes via their Smartphone.
Investor Presentation (See Slide 14 For Financial Projections)
For information only. If interested please send us an email: info@gblcon.com and we will connect you with a qualified, licensed investment advisor for further guidance.
Chatham Rock Phosphate (NZP: TSX) – An undervalued play in the mining industry, as a long term play for Phosphate mining, will benefit the agricultural industry – which will always be in demand for quality sourced Phosphate.
On the road to be the premier supplier of direct application phosphate to the New Zealand and global agricultural sector.
For information only. If interested please send us an email: info@gblcon.com and we will connect you with a qualified, licensed investment advisor for further guidance.
Turmalina Metals Corp. (TSX-V: TBX, OTCQX: TBXXF) is looking for investment in its San Francisco project in San Juan, Argentina, a company that drilled exceptionally high grades of gold in a phase 1 drilling program.
This high-grade gold-copper-silver project boasts a tourmaline breccia target style that is often overlooked by many explorers. The leadership team behind TBX is responsible for multiple gold-copper-silver-molybdenum discoveries and are highly experienced in this deposit style.
Turmalina recently announced it completed a large project-scale field program and is now preparing a phase 2 drill program, to follow up on the outstanding results at the SFLD breccia while also concurrently testing newly identified and prioritized exploration targets.
Turmalina is in a stable position in uncertain times. Having completed its three-month field program, it has data of targets modeled with drillers ready to commence work. The company is well-financed via a recently completed oversubscribed financing done at $0.70.
If interested please send us an email: info@gblcon.com and we will connect you with a qualified, licensed investment advisor for further guidance.
VLife Centers – a Premium Healthcare Centers Group – is raising $10M (CAD) brokered by Echelon Wealth Partners. The financing will be closing shortly as we are through our minimum and have currently raised $6.8M (CAD).
The group will be using proceeds to open 3 medical centers in Canada in 2020, 2021, and expand throughout North America.
For information only. If interested please send us an email: info@gblcon.com and we will connect you with a qualified, licensed investment advisor for further guidance.
InnoCan Pharma (CSE: INNO) is an Israeli-based pharmaceutical tech company that is developing a new, CBD loaded exosome-based technology, called “CLX” which is planned to treat respiratory conditions caused by COVID-19 and other lung illnesses. We are raising up to $10,000,000 via a brokered prospectus financing by Mackie & Canaccord to help accelerate InnoCan’s research into this game changing treatment.
Offering: $0.20 unit with one warrant exercisable at $0.25 for 3 years